Product Details for NDA 050011
PATHOCIL (DICLOXACILLIN SODIUM)
EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: DICLOXACILLIN SODIUM
Proprietary Name: PATHOCIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050011
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
PATHOCIL (DICLOXACILLIN SODIUM)
Proprietary Name: PATHOCIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050011
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: DICLOXACILLIN SODIUM
Proprietary Name: PATHOCIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050011
Product Number: 003
Approval Date: Mar 28, 1983
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PATHOCIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050011
Product Number: 003
Approval Date: Mar 28, 1983
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status: Discontinued
Patent and Exclusivity Information